Published in Cancer Weekly, April 4th, 2006
The article "Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma" and published in the New England Journal of Medicine, showed results from the addition of thalidomide to a myeloma treatment regimen that included high-dose, melphalan-based chemotherapy in a setting of tandem peripheral blood stem-cell...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.